Companies like IPCA and Zydus Cadila are the major
India is the biggest manufacturer of hydroxychloroquine, the anti-malarial drug that is being touted as 'game-changer' in the fight against COVID-19 and is being
The country has a production capacity of 40 tonnes of hydroxychloroquine (HCQ) every month, implying 20 crore tablets of 200 mg each
More than a billion Indians currently stand at the precipice of a massive increase in cases of coronavirus disease 2019 (COVID-19)
, 2019)
Apr 12, 2020, 02:38 PM | Updated 02:38 PM IST
New Delhi: The country’s largest manufacturers of anti-malarial drug hydroxychloroquine (HCQ) — Ipca laboratories and Zydus Cadila — have bagged orders from the Ministry of Health and Family Welfare to supply around 10 crore tablets
First of all states in India have surplus amount
3 Bn in 2020
India recently agreed to export HCQ to the US and Brazil after requests from their Presidents